Literature DB >> 4028630

Efficacy of clonidine and of methadone in the rapid detoxification of patients dependent on heroin.

J Camí, S de Torres, L San, A Solé, D Guerra, B Ugena.   

Abstract

The efficacy of a rapid detoxification schedule (8 to 10 days) with clonidine or methadone was evaluated in 30 patients addicted to heroin. The dose of study drug was preestablished according to the subject's weight and the amount of opioid consumption, and the total daily dose was reduced by approximately 15% during the study. All subjects completed the detoxification program and stayed in the hospital for at least 12 days. Clonidine and methadone therapies proved to be highly effective. There was a marked reduction in anxiety during opioid detoxification, although subjects' experiences differed according to the drug used. On the day of discharge, subjects who had received methadone still had attenuated withdrawal symptoms, whereas there were no such symptoms in the clonidine group. Muscular aching, flatulence, and daily drowsiness were more common among subjects in the methadone group, while subjects in the clonidine group had more sleep disturbances and weeping. Syncopal episodes and bradycardia occurred more frequently in the clonidine group.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4028630     DOI: 10.1038/clpt.1985.182

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  9 in total

Review 1.  The medical management of adolescent heroin dependence.

Authors:  A B Rowan; P J Fudala; J Mulligan
Journal:  Curr Psychiatry Rep       Date:  2000-12       Impact factor: 5.285

2.  Hypocretin receptor 2 antagonism dose-dependently reduces escalated heroin self-administration in rats.

Authors:  Brooke E Schmeichel; Estelle Barbier; Kaushik K Misra; Candice Contet; Joel E Schlosburg; Dimitri Grigoriadis; John P Williams; Camilla Karlsson; Caleb Pitcairn; Markus Heilig; George F Koob; Leandro F Vendruscolo
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

3.  [The drug addict in prison: Medical response and its limitations].

Authors:  R Jeanmonod; T Harding
Journal:  Soz Praventivmed       Date:  1988

4.  Escalation patterns of varying periods of heroin access.

Authors:  Leandro F Vendruscolo; Joel E Schlosburg; Kaushik K Misra; Scott A Chen; Thomas N Greenwell; George F Koob
Journal:  Pharmacol Biochem Behav       Date:  2011-03-23       Impact factor: 3.533

Review 5.  Methadone at tapered doses for the management of opioid withdrawal.

Authors:  Laura Amato; Marina Davoli; Silvia Minozzi; Eliana Ferroni; Robert Ali; Marica Ferri
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

Review 6.  Opioid dependence treatment: options in pharmacotherapy.

Authors:  Angela L Stotts; Carrie L Dodrill; Thomas R Kosten
Journal:  Expert Opin Pharmacother       Date:  2009-08       Impact factor: 3.889

Review 7.  Alpha₂-adrenergic agonists for the management of opioid withdrawal.

Authors:  Linda Gowing; Michael Farrell; Robert Ali; Jason M White
Journal:  Cochrane Database Syst Rev       Date:  2016-05-03

8.  Effect of morphine and abstinence syndrome on [3H]bromoxidine binding to alpha 2-adrenoceptors in rat brain.

Authors:  A Fernández-López; C Soria; V Revilla; T Gómez; P Calvo
Journal:  Neurochem Res       Date:  1994-04       Impact factor: 3.996

9.  Clonidine is better than zopiclone for insomnia treatment in chronic pain patients.

Authors:  Olumuyiwa A Bamgbade; Jemima Tai-Osagbemi; Daniel O Bamgbade; Ofeoritse Murphy-Akpieyi; Abisola Fadire; Nikki K Soni; Lise Mumporeze
Journal:  J Clin Sleep Med       Date:  2022-06-01       Impact factor: 4.324

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.